Determination of plasma D-lactate,diamine oxidase and endotoxin and significance in patients of hepatic cirrhosis

CLINICAL FOCUS ›› 2009, Vol. 24 ›› Issue (3): 219-221.

Previous Articles Next Articles

Determination of plasma D-lactate,diamine oxidase and endotoxin and significance in patients of hepatic cirrhosis

GAO Jin-sheng;SHI Zhi-min;HAN Zuan-ye;LI Xiao-tian;YANG Shu-liang

Online:2009-02-05 Published:2009-02-05

Abstract

CLC Number:

R575.2

GAO Jin-sheng;SHI Zhi-min;HAN Zuan-ye;LI Xiao-tian;YANG Shu-liang. Determination of plasma D-lactate,diamine oxidase and endotoxin and significance in patients of hepatic cirrhosis[J]. CLINICAL FOCUS, 2009, 24(3): 219-221.

Add to citation manager EndNote|Ris|BibTeX

URL: https://lchc.magtechjournal.com/EN/

https://lchc.magtechjournal.com/EN/Y2009/V24/I3/219

[1]	Su Rui, Wang Cunkai, Wang Dingxin, Cai Conghui, Zhang Jian, Hou Hongtao, Bai Yun. Efficacy and safety of anticoagulant therapy in patients with cirrhosis: A meta-analysis [J]. Clinical Focus, 2025, 40(4): 293-303.
[2]	Lin Tao, Du Taoming, Li Ya, Feng Yuling, Song Huizhen, Yu Qin. Value of T₂WI signal intensity and gadobemeglumine enhanced MRI hepatobiliary phase parameters in evaluating liver function of cirrhosis patients [J]. Clinical Focus, 2025, 40(3): 251-256.
[3]	Qian Chenying, Yan Wenjun, Huang Yan, Zhao Zhi. Analysis of risk factors for multidrug-resistant bacterial infection in patients with decompensated cirrhosis [J]. Clinical Focus, 2025, 40(2): 143-146.
[4]	Zhang Shasha, Zhao Yingchun, Zhou Hongxia. Effect of low-level viremia on the incidence of hepatocellular carcinomas in patients with hepatitis B cirrhosis treated with entecavir [J]. Clinical Focus, 2024, 39(11): 980-983.
[5]	. [J]. Clinical Focus, 2024, 39(7): 658-663.
[6]	Wang Qingli;Yang Lin;Liu Qi. Clinical observation on effect of coffeic acid on leukocyte anal platelet count in patients with cirrhosis [J]. Clinical Focus, 2015, 30(9): 1027-1.0281e+007.
[7]	Ge Xiuzhen;Wang Yuming;Zheng Zhongqing;Wang Tao;Wang Bangmao. Risk factors in poor prognosis after endoscopic variceal ligation and endoscopic injection sclerotherapy of esophageal varices caused by liver cirrhosis [J]. Clinical Focus, 2015, 30(3): 250-252256.
[8]	. [J]. CLINICAL FOCUS, 2014, 29(3): 350-350.
[9]	HE Qing-hong;HUANG Wei. Application of color Doppler sonography predicting cirrhotic portal hypertension with esophageal varices rupture hemorrhage [J]. CLINICAL FOCUS, 2014, 29(3): 295-297.
[10]	XIAO Qi;FENG Ai-dong;LIU Zhi-quan;FENG Jun-hua;DU Rui-qing;YE Li-hong;MEI Zhi-qin;DAI Er-hei. Value and impact factors of transient edoi:graphy in diagnosis of hepatitis B cirrhosis [J]. CLINICAL FOCUS, 2013, 28(8): 855-857860.
[11]	ZHAO Tian-yu;MA Chun-ye;LI Chun-yan. Analysis of cirrhosis patients with hepatic encephalopathy prognostic factors [J]. Clinical Focus, 2013, 28(4): 406-408.
[12]	WANG Jun-ming;CHEN Chun-yan;LI Yan;HANG Jing-xian;ZHANG Zhi-gang. Relationship between fatty liver and carotid atherosclerosis in different age populations [J]. Clinical Focus, 2013, 28(1): 11-13.
[13]	ZHANG Jing;SANG Hai-tong. Impact of hepatorenal function and clinical outcomes in patients with liver cirrhosis combined with systemic inflammatory response syndrome [J]. Clinical Focus, 2012, 27(24): 2117-2120.
[14]	. [J]. Clinical Focus, 2012, 27(22): 1979-1980.
[15]	LI Chun-sheng;GUO Jin-bo;XU Yun-feng;TIAN Hui;WEI Juan;ZHANG Guo-zun;LIU Lei;FANG Shu-ming;ZHANG Xiao-lan. Effects of salvia miltiorrhiza monomer IH764-3 on collagen metabolism and mechanism in hepatic stellate cells [J]. Clinical Focus, 2012, 27(17): 1502-1505.

Determination of plasma D-lactate,diamine oxidase and endotoxin and significance in patients of hepatic cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments